MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-11
DOI
10.1038/s41598-017-05801-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer
- (2016) Jing-Ye Hu et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Treatment of muscle-invasive bladder cancer: A systematic review
- (2016) Roger Chou et al. CANCER
- Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer
- (2016) Li-Peng Jiang et al. Future Oncology
- High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma
- (2016) Yihuan Luo et al. MEDICINE
- High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro
- (2016) F. Wang et al. MOLECULAR CANCER THERAPEUTICS
- miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2
- (2016) Yu Gao et al. Oncotarget
- Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment
- (2015) Margaritis Avgeris et al. CARCINOGENESIS
- microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
- (2015) Adam E. Frampton et al. EUROPEAN JOURNAL OF CANCER
- Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence
- (2015) Angeline S. Andrew et al. INTERNATIONAL JOURNAL OF CANCER
- Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer
- (2015) Jinfeng Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: A systematic review and meta-analysis
- (2015) Zahra Jamali et al. ORAL ONCOLOGY
- DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer
- (2015) Chun-Te Wu et al. Oncotarget
- MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1
- (2015) Yang Peng et al. Oncotarget
- MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer
- (2015) Jinfeng Wang et al. PLoS One
- MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
- (2015) Xin Zhang et al. PLoS One
- Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer
- (2014) Rongkai Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
- (2014) R. M. Drayton et al. CLINICAL CANCER RESEARCH
- Nucleic acid-based tissue biomarkers of urologic malignancies
- (2014) Dimo Dietrich et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use?
- (2014) Francesca Sanguedolce et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer
- (2014) Xiumei Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis
- (2014) Xin Zhou et al. PLoS One
- Increased expression of miR-222 is associated with poor prognosis in bladder cancer
- (2014) Dong-qing Zhang et al. World Journal of Surgical Oncology
- Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis
- (2014) Xiongbing Zu MEDICAL SCIENCE MONITOR
- Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients
- (2013) Hui-chan He et al. BMC GENOMICS
- miR-214 Coordinates Melanoma Progression by Upregulating ALCAM through TFAP2 and miR-148b Downmodulation
- (2013) Elisa Penna et al. CANCER RESEARCH
- Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer
- (2013) S. Wang et al. Clinical & Translational Oncology
- PI3K/AKT pathway activation in bladder carcinogenesis
- (2013) Julien Calderaro et al. INTERNATIONAL JOURNAL OF CANCER
- Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/β-Catenin Signaling
- (2013) Xiaoping Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer
- (2013) Wen-Jing Liu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome
- (2013) Nadine Ratert et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis
- (2013) ChongLek Lee et al. MEDICAL ONCOLOGY
- Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
- (2013) Kristina Schee et al. PLoS One
- miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma
- (2013) Min Deng et al. TUMOR BIOLOGY
- Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma
- (2012) Xin Huang et al. AMERICAN JOURNAL OF PATHOLOGY
- miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer
- (2012) Patricia Puerta-Gil et al. AMERICAN JOURNAL OF PATHOLOGY
- Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways
- (2012) Shunsuke Noguchi et al. CANCER LETTERS
- Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer
- (2012) Sheng Wang et al. Diagnostic Pathology
- MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17
- (2012) Ke Xu et al. EXPERIMENTAL CELL RESEARCH
- microRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer
- (2012) Géraldine Pignot et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
- (2012) Cheng-Xiong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 7
- (2012) Rui-Qing Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma
- (2012) Tsung-Chieh Shih et al. JOURNAL OF HEPATOLOGY
- Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer
- (2012) Apostolos Zaravinos et al. JOURNAL OF UROLOGY
- MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma
- (2012) Sheng-Dong Huang et al. Molecular Cancer
- The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
- (2011) S B Villadsen et al. BRITISH JOURNAL OF CANCER
- MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells
- (2011) Syunsuke Noguchi et al. CANCER LETTERS
- Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase
- (2011) Assia Derfoul et al. CARCINOGENESIS
- Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
- (2011) Derya Tilki et al. EUROPEAN UROLOGY
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
- (2011) C Quintavalle et al. ONCOGENE
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
- (2010) O. A. Kent et al. GENES & DEVELOPMENT
- Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
- (2009) L. Dyrskjot et al. CANCER RESEARCH
- MicroRNA-143 as a Tumor Suppressor for Bladder Cancer
- (2009) Tianxin Lin et al. JOURNAL OF UROLOGY
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
- (2009) Tetsuya Ueda et al. LANCET ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31
- (2008) Srinivas Veerla et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More